Polymicrobial sepsis

Sendi, Parham; Graber, Peter; Lötscher, Rene
August 2006
CMAJ: Canadian Medical Association Journal;8/29/2006, Vol. 175 Issue 5, p474
Academic Journal
The article presents information on an elderly patient suffering from polymicrobial sepsis. Blood sample taken from the patient revealed polymicrobial sepsis. The organisms responsible for the sepsis include the Mitis-group streptococci and Klebsiella pneumoniae. The patient died of septic shock despite the administration of proton-pump inhibitors, packed red blood cells, fresh frozen plasma and antibiotics.


Related Articles

  • Early source control in sepsis. De Waele, Jan J. // Langenbeck's Archives of Surgery;Jun2010, Vol. 395 Issue 5, p489 

    Early appropriate therapy in terms of early fluid resuscitation and early antibiotic therapy is beneficial in patients with severe sepsis and septic shock. The purpose of this review is to address the role of early source control in the management of patients with severe sepsis. Establishing a...

  • Decreasing Mortality in Severe Sepsis and Septic Shock Patients by Implementing a Sepsis Bundle in a Hospital Setting. Shiramizo, Sandra Christina Pereira Lima; Marra, Alexandre R.; Durão, Marcelino S.; Paes, Ángela T.; Edmond, Michael B.; Santos, Oscar Fernando Pavão dos // PLoS ONE;2011, Vol. 6 Issue 11, p1 

    Background: The Surviving Sepsis Campaign (SSC) guidelines for the management of severe sepsis (SS) and septic shock (SSh) have been recommended to reduce morbidity and mortality. Materials and Methods: A quasi-experimental study was conducted in a medical-surgical ICU. Multiple interventions to...

  • Çocuklarda GeniÅŸlemiÅŸ Spektrumlu β-Laktamaz Ureten Klebsiella Kan Akımı Enfeksiyonunda Risk Faktörleri ve Klinik Sonucları: BeÅŸ Yıllık Çalışma. Çelebi, Solmaz; Tuncer, Esra; Hacımustafaoğlu, Mustafa; Özkaya, Güven // Journal of Pediatric Infection / Cocuk Enfeksiyon Dergisi;Sep2008, Vol. 2 Issue 3, p84 

    Aim: The extended-spectrum beta lactamase (ESBL) producing Klebsiella species causes widespread problems in intensive care units. The aim of this study was to define the risk factors and clinical outcomes associated with ESBL-producing Klebsiella spp. bloodstream infections in children. Material...

  • Editorial [ Sepsis: From the Bench to the Bedside ]. Salomao, R. // Endocrine, Metabolic & Immune Disorders - Drug Targets;Jun2006, Vol. 6 Issue 2, p125 

    Sepsis: From the Bench to the Bedside The term sepsis derives from the Greek sepsis, which means putrefaction. The pathogenesis and clinical manifestations of sepsis result from a complex interaction between the host and the infecting microorganism. Evolving at different stages of a continuum...

  • Drotrecogin Alfa (Activated) in Septic Shock. Hollander, Judd E.; Nayyar, Vineet; Solano, Thomas; Thompson, B. Taylor; Ranieri, V. Marco // New England Journal of Medicine;9/6/2012, Vol. 367 Issue 10, p967 

    Several letters to the editor are presented in response to articles in previous issues including V. M. Ranieri et al's study titled "The Prospective Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis and Septic Shock (PROWESS-SHOCK) published in the May 31, 2012 issue.

  • Septic shock and chemotherapy-induced cytopenia: effects on microcirculation. Karvunidis, Thomas; Chvojka, Jiri; Lysak, Daniel; Sykora, Roman; Krouzecky, Ales; Radej, Jaroslav; Novak, Ivan; Matejovic, Martin // Intensive Care Medicine;Aug2012, Vol. 38 Issue 8, p1336 

    Purpose: Neutrophil and platelet activation and their interactions with endothelial cells are considered central features of sepsis-induced microcirculatory alterations. However, no study has evaluated the microvascular pattern of septic shock patients with chemotherapy-induced severe cytopenia....

  • How well does TOKS identify patients with severe sepsis or septic shock? Tanderup, Anette; Storgaard, Merete; Lassen, Annmarie // Scandinavian Journal of Trauma, Resuscitation & Emergency Medici;2013, Vol. 21 Issue Suppl 2, p1 

    The article presents a study on the capacity of the "Tidlig Opsporing af Kritisk Sygdom" (TOKS) system to identify patients who either have or develop severe sepsis or septic shock within 24 hours after arriving in a hospital. The study found that 14 percent of the patients who develop severe...

  • Targeting the Bombesin/Gastrin-Releasing Peptide Receptor to Treat Sepsis. Cornelio, Daniela B.; Dal-Pizzol, Felipe; Roesler, Rafael; Schwartsmann, Gilberto // Recent Patents on Anti-Infective Drug Discovery;Nov2007, Vol. 2 Issue 3, p178 

    Sepsis is a complex, multifactorial syndrome that can develop into conditions of different severity, described as septic shock or severe sepsis. In spite of the great progress in understanding the mechanisms involved in the pathogenesis and management of sepsis, only a few therapeutic strategies...

  • Microcirculatory changes during open label magnesium sulphate infusion in patients with severe sepsis and septic shock. Pranskunas, Andrius; Vellinga, Namkje AR; Pilvinis, Vidas; Koopmans, Matty; Boerma, E. Christiaan // BMC Anesthesiology;2011, Vol. 11 Issue 1, p12 

    Background: Microcirculatory alterations play a pivotal role in sepsis and persist despite correction of systemic hemodynamic parameters. Therefore it seems tempting to test specific pro-microcirculatory strategies, including vasodilators, to attenuate impaired organ perfusion. As opposed to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics